| Dr Garrett Venable, MD | |
|
10101 Park Rowe Ave, Baton Rouge, LA 70810-1686 | |
| (225) 768-2164 | |
| Not Available |
| Full Name | Dr Garrett Venable |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 10101 Park Rowe Ave, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316300502 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 333350 (Louisiana) | Primary |
| Entity Name | Neuromedical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740216399 PECOS PAC ID: 6103716477 Enrollment ID: O20040318001606 |
News Archive
It is 30 years since the beginning of the AIDS epidemic. It was fatal then but has now become a treatable, if still incurable, chronic illness. AIDS therapy now has tools that prolong the lives of people infected with the virus and prevent others from acquiring it. They range from antiretroviral therapy (ART), to circumcision and campaigns to reduce promiscuity. On the horizon are gels and pills that protect against infection during intercourse. Even the outlook for an AIDS vaccine is no longer as bleak as it used to be.
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).
Prothelia Incorporated (Prothelia) and University of Nevada, Reno announce that they have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient congenital muscular dystrophy (MDC1A), a life-threatening, ultra-rare disease caused by a genetic deficiency of the Laminin-211 protein.
Having close friends and staying in contact with family members offers a protective effect against the damaging effects of Alzheimer's disease according to research by physicians at Rush University Medical Center in Chicago. The study, which is currently posted online in The Lancet Neurology, will be published in the May print edition of the journal.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Garrett Venable, MD 10101 Park Rowe Ave Ste 200, Baton Rouge, LA 70810-1685 Ph: (225) 768-2164 | Dr Garrett Venable, MD 10101 Park Rowe Ave, Baton Rouge, LA 70810-1686 Ph: (225) 768-2164 |
News Archive
It is 30 years since the beginning of the AIDS epidemic. It was fatal then but has now become a treatable, if still incurable, chronic illness. AIDS therapy now has tools that prolong the lives of people infected with the virus and prevent others from acquiring it. They range from antiretroviral therapy (ART), to circumcision and campaigns to reduce promiscuity. On the horizon are gels and pills that protect against infection during intercourse. Even the outlook for an AIDS vaccine is no longer as bleak as it used to be.
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).
Prothelia Incorporated (Prothelia) and University of Nevada, Reno announce that they have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient congenital muscular dystrophy (MDC1A), a life-threatening, ultra-rare disease caused by a genetic deficiency of the Laminin-211 protein.
Having close friends and staying in contact with family members offers a protective effect against the damaging effects of Alzheimer's disease according to research by physicians at Rush University Medical Center in Chicago. The study, which is currently posted online in The Lancet Neurology, will be published in the May print edition of the journal.
› Verified 3 days ago
Scott W. Soleau, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10101 Park Rowe Ave, Suite 200, Baton Rouge, LA 70810 Phone: 225-769-2200 Fax: 225-768-2185 | |
Thomas B Flynn, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 10101 Park Rowe Ave, Suite 200, Baton Rouge, LA 70810 Phone: 225-769-2200 Fax: 225-768-2185 | |
Brandon Gerard Gaynor, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10101 Park Rowe Ave Ste 200, Baton Rouge, LA 70810 Phone: 225-769-2200 Fax: 225-768-2185 | |
John R Clifford, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 10101 Park Rowe Ave, Suite 200, Baton Rouge, LA 70810 Phone: 225-769-2200 Fax: 225-768-2185 | |
Dr. Marvin Dementreous Clifton, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4884 Constitution Ave, Ste 1e, Baton Rouge, LA 70808 Phone: 225-923-1621 Fax: 225-923-1623 | |
Dr. Anthony S Ioppolo, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 7777 Hennessy Blvd Plaza 1, 709, Baton Rouge, LA 70808 Phone: 225-757-1960 Fax: 225-757-1959 |